Research programme: chronic obstructive pulmonary disease therapy - NeuroSearchAlternative Names: COPD therapeutics - NeuroSearch; NSD-503
Latest Information Update: 04 Feb 2011
At a glance
- Originator NeuroSearch
- Mechanism of Action Ion channel agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Chronic obstructive pulmonary disease
Most Recent Events
- 14 Jul 2006 NSD 503 is available for licensing (http://www.neurosearch.com)
- 05 Oct 2005 Preclinical trials in Chronic obstructive pulmonary disease in Sweden (unspecified route)